Lonza Group AG LON.N-CH:Swiss Exchange

*Data is delayed | Exchange | CHF
Last | 5:31 PM CEST
527.80quote price arrow up+14.00 (+2.72%)
Volume
141,808
52 week range
308.60 - 599.40
Loading...
  • Open518.60
  • Day High527.80
  • Day Low516.60
  • Prev Close513.80
  • 52 Week High599.40
  • 52 Week High Date06/06/23
  • 52 Week Low308.60
  • 52 Week Low Date10/26/23

Key Stats

  • Market Cap39,758.97M
  • Shares Out72.12M
  • 10 Day Average Volume-
  • Dividend4.00
  • Dividend Yield0.76%
  • Beta1.97
  • YTD % Change-

KEY STATS

  • Open518.60
  • Day High527.80
  • Day Low516.60
  • Prev Close513.80
  • 52 Week High599.40
  • 52 Week High Date06/06/23
  • 52 Week Low308.60
  • 52 Week Low Date10/26/23
  • Market Cap39,758.97M
  • Shares Out72.12M
  • 10 Day Average Volume-
  • Dividend4.00
  • Dividend Yield0.76%
  • Beta1.97
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)8.87
  • P/E (TTM)59.50
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Lonza Group AG

 

Profile

MORE
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics...
Albert Baehny
Interim Chief Executive Officer
Philippe Deecke
Chief Financial Officer, Member of the Executive Committee
Address
Muenchensteinerstrasse 38
Basel
4002
Switzerland